An Overview of the Potential for Pharmacokinetic Interactions Between Drugs and Cannabis Products in Humans

Pharmaceutics, Journal Year: 2025, Volume and Issue: 17(3), P. 319 - 319

Published: March 1, 2025

Cannabis is the most commonly used illicit substance worldwide. Recent years have seen an increase in cannabis consumption, and with new approvals therapeutic indications, there are challenges minimizing risks interactions between cannabis-based products, prescription drugs, other approved substances of abuse. Thus, identifying enzymes metabolizing cannabinoid drugs their relationship crucial for understanding potential effects simultaneous use. This article offers a comprehensive review pharmacokinetic as well It also compiles existing evidence these describes clinical outcomes associated inhibition or induction various enzymes.

Language: Английский

A Cross-Sectional Study on Youth and Over-the-Counter CBD Products: Understanding the Current Landscape in Spain

International Journal of Mental Health and Addiction, Journal Year: 2025, Volume and Issue: unknown

Published: April 24, 2025

Language: Английский

Cannabidiol Use Among Older Adults: Associations with Cannabis Use, Physical and Mental Health, and Other Substance Use

Clinical Gerontologist, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 13

Published: Nov. 22, 2024

To examine older adults' cannabidiol (CBD) use and its associations with cannabis physical/mental health other substance problems.

Language: Английский